Pulmonx financials at a glance

+ Portfolio

The revenue of Pulmonx is reported as 0.06868 billion Dollars in the fiscal year 2023. The earnings were -1.6 Dollars per share in 2023, which was 0.63 lower than 2022. And about -0.03842 billion Dollars are reported as free cash flow in the financials of Pulmonx 2023. No dividends were paid to the shareholders of the Pulmonx stock NasdaqGS:LUNG in the financial year 2023.

$68.68M

Revenue

$-1.60

Earnings Per Share

73.90%

Gross Margin %

$-32.10M

Free Cash Flow

Revenue

68.68

Earnings Per Share

-1.60

Gross Margin %

73.90

Free Cash Flow

-32.10

Financials

Year	Year	TTM	2023	2022	2021	2020
Rev.	Revenue	N/A	$68.68M	$53.66M	$48.42M	$32.73M
GM %	Gross Margin %	73.33%	73.90%	74.29%	73.59%	64.77%
OM	Operating Margin	-96.64%	-90.19%	-,109.27%	-97.70%	-98.77%
EPS	Earnings Per Share	$-1.62	$-1.60	$-1.59	$-1.35	$-3.48
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	-0.00%	-0.00%
Sha.	Shares	N/AM	38.54M	37.65M	37.02M	35.69M
OCF	Operating Cash Flow	N/A	$-37.61M	$0.00M	$0.00M	$-29.76M
FCF	Free Cash Flow	N/A	$-32.10M	$0.00M	$0.00M	$-31.54M
FCFS	Free Cash Flow Per Share	$-1.05	$-1.01	$-1.25	$-1.25	$-3.10

Pulmonx financials at a glance

Financials

Discover